The National Cancer Institute of Kenya’s efforts to reduce the national cancer burden have advanced with an expanded collaboration. Dr. Ouma Oluga, Principal Secretary for Medical Services, hosted representatives from the Merck Foundation and NCI-K, led by CEO Dr. Elias Melly, to formalize this partnership.
The meeting, held today, the 29th of October, 2025, at Afya House in Nairobi, focused on strengthening collaboration in cancer prevention, early detection, and treatment.
The discussions were centered on transforming the cancer care continuum in the country, from prevention to treatment, by expanding joint programs that will significantly enhance cancer diagnosis and management. The partnership strategically merges the Merck Foundation’s global expertise with Kenya’s growing healthcare infrastructure.
This collaboration is focused on actionable steps to improve access and quality, particularly in underserved communities, including prioritizing early detection, Affordable Treatment Access, and Patient Support Initiatives.
Dr. Oluga strongly emphasized that such partnerships are vital for achieving the government’s goals of quality and equitable healthcare access. “Cancer is one of the fastest-rising health challenges globally. By joining forces with partners like Merck Foundation and NCI-K, we can strengthen our health system’s capacity to prevent, detect, and treat cancer early, saving more lives,” said Dr. Oluga.
The joint initiatives will bring a positive effect in regard to: building capacity across the entire healthcare system, enhancing public awareness, and ultimately contributing to a significant reduction in Kenya’s cancer burden. This alliance powerfully reinforces the Ministry’s commitment to delivering accessible, affordable, and quality healthcare for all citizens
Leave a Reply